Veterinary Oncology Market, by Animal Type (Companion Animal (Equine, Canine, and Feline), and Livestock Animal), by Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), by Mode of Administration (Oral and Intravenous), by Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Multiple Myeloma), by Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines. A veterinary oncologist has specialized knowledge in the diagnosis of cancer, the staging of tumors, the development of treatment plans, and the administration of chemotherapy. Veterinary oncologists determine the most appropriate course of treatment and coordinate the treatment program for pets with cancer. They also frequently serve as consultants to veterinarians in private practice to ensure that their patients receive the best treatment possible for their cancer. There is ongoing research and clinical trials to develop new and effective treatment options for pets with cancer. Many veterinary medical advances have been made in recent years. One breakthrough treatment was the development of the ONCEPT Canine Melanoma Vaccine. ONCEPT Canine Melanoma Vaccine therapeutic vaccine is manufactured by Merial, a world leading, innovation-driven animal health company and the maker of many canine vaccines, including the world's leading rabies vaccines.
Market Dynamics
Increasing adoption of inorganic growth strategies such as partnership by the key players in the market for research and development program and awareness programs for the veterinary oncology treatment is expected to drive the market over the forecast period. For instance, in August 2022, a Siemens Healthineers company, a healthcare company, and the University of Illinois Veterinary Teaching Hospital partnered to provide a 2-day clinical educational program in veterinary radiation oncology. According to a company release, the inaugural clinical ‘school,’ hosted by Varian Veterinary Oncology, occurred on from August 12 – 13, 2022. Custom designed for the veterinary radiation oncology team, the curriculum will hone in on clinical workflows, clinical implementation, treatment planning, and treatment delivery. Participants will obtain instruction on radiotherapy and similar topics and will participate in hands-on workshops.
Key features of the study:
- This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global veterinary oncology market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global veterinary oncology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market
- Global Veterinary Oncology Market, By Animal Type:
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
- Global Veterinary Oncology Market, By Therapy Type:
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
- Global Veterinary Oncology Market, By Mode of Administration:
- Oral
- Intravenous
- Global Veterinary Oncology Market, By Application:
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Multiple Myeloma
- Global Veterinary Oncology Market, By Distribution Channel:
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
- Global Veterinary Oncology Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Zoetis Inc.*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA
Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description Market Definition and Scope o Executive Summary Market Snapshot, By Animal Type Market Snapshot, By Therapy Type Market Snapshot, By Mode of Administration Market Snapshot, By Application Market Snapshot, By Distribution Channel Market Snapshot, By Region o Coherent Opportunity Map (COM) 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics Drivers Restraints Market Opportunities o Impact Analysis o Initiatives for Prevention and Control of Veterinary Oncology o Radiation Therapy o Market Trends o Product Recall o Epidemiology o Key Developments o Cancers in Cats o Cancers in Dogs o Chemotherapy Agents Commonly used in Veterinary Medicine o Regulatory Scenario o Veterinary Medicines: Patent Information o Veterinary Cancer: Awareness Campaign o Mergers and Acquisitions o PEST Analysis 4. Global Veterinary Oncology Market- Impact of Coronavirus (Covid-19) Pandemic o Overall Impact o Government Initiatives o COVID-19 Impact on the market 5. Global Veterinary Oncology Market, By Animal Type, 2017 – 2030, (US$ Million) o Overview Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2017 – 2030 Segment Trends o Companion Animal Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) Equine o Overview o Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) Canine o Overview o Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) Feline o Overview o Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Livestock Animal Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 6. Global Veterinary Oncology Market, By Therapy Type, 2017 – 2030, (US$ Million) o Overview Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2017 – 2030 Segment Trends o Chemotherapy Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Combination Therapy Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Immunotherapy Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Targeted Therapy Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 7. Global Veterinary Oncology Market, By Mode of Administration, 2017 – 2030, (US$ Million) o Overview Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2017 – 2030 Segment Trends o Oral Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Intravenous Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 8. Global Veterinary Oncology Market, By Application, 2017 – 2030, (US$ Million) o Overview Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2017 – 2030 Segment Trends o Canine Lymphoma Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Osteosarcoma (OSA) Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Mast Cell Cancer Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Melanoma Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Multiple Myeloma Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 9. Global Veterinary Oncology Market, By Distribution Channel, 2017 – 2030, (US$ Million) o Overview Market Share Analysis, 2022 and 2030 (%) Y-o-Y Growth Analysis, 2017 – 2030 Segment Trends o Hospital Pharmacies Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Government Agencies Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) o Retail Pharmacies Overview Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million) 10. Global Veterinary Oncology Market, By Region, 2017 – 2030, (US$ Million) o Introduction Market Share Analysis, By Region, 2022 and 2030 (%) Y-o-Y Growth Analysis, For Regions, 2017–2030 Regional Trends o North America Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.S. o Canada o Latin America Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o Brazil o Mexico o Argentina o Rest of Latin America o Europe Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o U.K. o Germany o Italy o France o Spain o Russia o Rest of Europe o Asia Pacific Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o China o India o Japan o ASEAN o Australia o South Korea o Rest of Asia Pacific o Middle East Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million) o GCC o Israel o Rest of Middle East o Africa Introduction Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million) Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million) o North Africa o Central Africa o South Africa 11. Competitive Landscape o Company Profiles Zoetis Inc. o Company Highlights o Product Portfolio o Key Highlights o Financial Performance o Strategies Elanco AB Science Boehringer Ingelheim International GmbH Zenoaq VetDC Morphogenesis, Inc. Karyopharm Therapeutics, Inc. Regeneus Ltd. AdvaVet, Inc. Rhizen Pharmaceutical SA o Analyst Views 12. Section o References o Research Methodology o About Us *Browse 47 market data tables and 45 figures on "Global Veterinary Oncology Market” - forecast to 2030
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook